Loading…
Profusa, Inc. is projected to rise to $2.30 by 2027, a +8% move from its current price of $2.12. PFSA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.86 | $2.12 | $2.41 | -0.14% |
| Jul 14 | $1.76 | $2.11 | $2.54 | -0.29% |
| Jul 15 | $1.68 | $2.11 | $2.65 | -0.43% |
| Jul 16 | $1.62 | $2.11 | $2.74 | -0.57% |
| Jul 17 | $1.57 | $2.10 | $2.82 | -0.72% |
| Jul 18 | $1.53 | $2.10 | $2.90 | -0.86% |
| Jul 19 | $1.48 | $2.10 | $2.97 | -1.00% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.48 | $2.10 | $2.97 | -1.00% |
| Week 2 | $1.27 | $2.08 | $3.39 | -2.00% |
| Week 3 | $1.13 | $2.06 | $3.75 | -2.98% |
| Week 4 | $1.02 | $2.04 | $4.07 | -3.95% |
| Week 5 | $0.9294 | $2.02 | $4.37 | -4.92% |
| Week 6 | $0.8546 | $2.00 | $4.66 | -5.87% |
| Week 7 | $0.7904 | $1.98 | $4.94 | -6.82% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Profusa, Inc. is a digital health technology company that develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery.
The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Profusa, Inc. trades under the symbol PFSA. Its current price is $2.12. The market cap is $1.12M and it ranks 5450. This places PFSA as a small-cap healthcare asset with a near-term price outlook described as Neutral by the forecast.
The forecast shows a flat to modest near-term path with a 2026 average price of $2.12 and a max of $2.70, yielding 0% ROI in that year. From 2027 onward, the model envisions a gradual climb toward higher averages and ROIs, culminating in a 2050 average of $6.78 with a 220% ROI and bullish sentiment in the long run.
Overall, the asset sits in the healthcare sector with a current price near $2 and a market cap of $1.12M. The multi-year outlook shifts from neutral in the near term to bullish over the longer horizon, suggesting potential upside if the catalysts align with the forecast path.
A major floor 95.6% below — a decisive break under it would weaken the trend.
The nearest floor, 95.6% below — buyers have tended to step in here.
The nearest ceiling, 32.5% above — a clean break opens room to run.
A major ceiling 107.1% above — clearing it would confirm fresh momentum.
Key PFSA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PFSA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.53 | Sell | $2.10 | Buy |
| MA 10 | $1.32 | Buy | $1.61 | Buy |
| MA 20 | $0.7585 | Buy | $1.10 | Buy |
| MA 50 | $0.5496 | Buy | $0.882 | Buy |
| MA 100 | $0.72 | Buy | $3.48 | Sell |
| MA 200 | $7.02 | Sell | $20.78 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 70.25 | Sell |
| Stoch RSI (14) | 66.87 | Neutral |
| CCI (20) | 102.36 | Buy |
| Williams %R (14) | -25.41 | Info |
| MACD (12,26,9) | 0.26 | Buy |
| ROC (12) | 1372.22 | Buy |
| Bollinger %B (20,2) | 0.83 | Neutral |
| Stochastic %K (14) | 74.59 | Neutral |
| TRIX (15) | 9.12 | Buy |
| Awesome (5,34) | 1.95 | Buy |
| Ultimate (7,14,28) | 75.63 | Sell |
| Momentum (10) | 2.00 | Buy |
| Aroon Osc (25) | 8.00 | Buy |
| Hull MA (9) | 3.06 | Sell |
| ADX (14) | 49.11 | Buy |
| ATR (14) | 0.22 | Info |
The 30-day technical picture is Neutral in sentiment terms. The RSI(14) is 70, indicating a relatively elevated near-term momentum level.
The stock shows a 50-day simple moving average of $0.5049 and a 200-day simple moving average of $7.12. These moving averages frame a wide range of potential near-term trading levels and suggest a mixed, ranged dynamic ahead.
In terms of support and resistance, there is support at $0.094 and resistance at $2.81. The 30-day price range spans from $0.6421 to $7.00, highlighting substantial historical volatility within the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.094 | $2.12 | $2.70 | 0% | Neutral | |
| $1.56 | $2.30 | $3.66 | +8% | Neutral | |
| $1.76 | $2.82 | $4.87 | +33% | Bullish | |
| $1.73 | $2.99 | $5.46 | +41% | Bullish | |
| $1.62 | $3.00 | $5.76 | +42% | Bullish | |
| $1.37 | $2.73 | $5.46 | +29% | Bullish | |
| $1.19 | $2.53 | $5.25 | +20% | Neutral | |
| $1.03 | $2.29 | $4.89 | +8% | Neutral | |
| $1.41 | $3.12 | $6.88 | +47% | Bullish | |
| $1.89 | $4.20 | $9.50 | +98% | Bullish | |
| $1.76 | $3.91 | $8.99 | +84% | Bullish | |
| $3.06 | $6.80 | $15.64 | +221% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.094 | $2.12 | $2.68 | +0.00% |
| August 2026 | $1.70 | $2.10 | $2.71 | -1.09% |
| September 2026 | $1.48 | $1.86 | $2.47 | -11.35% |
| October 2026 | $1.41 | $1.81 | $2.45 | -2.84% |
| November 2026 | $1.51 | $1.95 | $2.70 | +8.07% |
| December 2026 | $1.47 | $1.92 | $2.70 | -1.48% |
Click any year to see its month-by-month PFSA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, PFSA could reach as high as $2.70, with a base case around $2.12 and support toward $0.094 — roughly 0% from $2.12. A consolidation phase looks the most probable path here.
Expect PFSA to range from $1.56 to $3.66 through 2027. The $2.30 average target implies a +8% move from current prices. That is up +8% on the projected 2026 average. Price action looks broadly range-bound.
The PFSA price prediction for 2028 points to an average of $2.82 (low $1.76, high $4.87) — a potential gain of +33% on today's $2.12. Buyers look set to stay in control over this stretch.
In 2029, PFSA is projected to trade between $1.73 and $5.46, averaging $2.99 — a potential gain of +41% from today's $2.12. That is up +6% on the projected 2028 average. Momentum favours further upside here.
Profusa, Inc.'s 2030 outlook centres on $3.00, within a $1.62 to $5.76 range. That is up 0% on the projected 2029 average. That marks a +42% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, PFSA could reach as high as $5.46, with a base case around $2.73 and support toward $1.37 — roughly +29% from $2.12. Momentum favours further upside here.
Expect PFSA to range from $1.19 to $5.25 through 2032. The $2.53 average target implies a +20% move from current prices. That is -7% versus the projected 2031 average. A consolidation phase looks the most probable path here.
The PFSA price prediction for 2033 points to an average of $2.29 (low $1.03, high $4.89) — a potential gain of +8% on today's $2.12. Price action looks broadly range-bound.
In 2034, PFSA is projected to trade between $1.41 and $6.88, averaging $3.12 — a potential gain of +47% from today's $2.12. That is up +37% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Profusa, Inc.'s 2035 outlook centres on $4.20, within a $1.89 to $9.50 range. That is up +34% on the projected 2034 average. That marks a +98% change versus current levels. Momentum favours further upside here.
By 2040, PFSA could reach as high as $8.99, with a base case around $3.91 and support toward $1.76 — roughly +84% from $2.12. Buyers look set to stay in control over this stretch.
Expect PFSA to range from $3.06 to $15.64 through 2050. The $6.80 average target implies a +221% move from current prices. That is up +74% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in PFSA today (≈ 471.698113 PFSA) could be worth
$3,206.78
+$2,206.78 (+221%) by 2050 · US Dollar
Based on the average projected PFSA price of $6.8 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PFSAwould be worth at today's price.
$1,000 invested in PFSA on Jul 11, 2025 (≈ 5.333333 PFSA) would be worth
$11.31
-$988.69 (-98.9%) today · 0.01× · US Dollar
Based on a PFSA entry price of $187.5 vs. today's $2.12.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.094 | $22,553.19 | +2155.3% |
| 1 month ago | $0.249 | $8,514.06 | +751.4% |
| 3 months ago | $0.865 | $2,450.87 | +145.1% |
| 6 months ago | $6.68 | $317.6 | -68.2% |
| 1 year ago | $187.5 | $11.31 | -98.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PFSA forecast.
Our base-case forecast reaches $4.20 around 2050.
Implied market cap at $4.20: $2.23M
The multi-year forecast paints a bullish path beyond 2026, with steady, higher average prices and meaningful ROIs in later years. Notably, 2030 shows an average price of $3.00 with an ROI of 41.7% and a bullish sentiment. The 2040 forecast lifts the average to $3.91 with an 84.4% ROI, underscoring stronger upside potential in the longer run.
By 2050, the average is projected at $6.78 with a 220% ROI, indicating substantial long-term appreciation under the model’s trajectory.
In the nearer stretch, 2028–2029 show positive momentum with rising averages and double-digit ROIs, reinforcing a bullish tilt into the 2030s. While the forecast includes upside potential, it also carries uncertainty and is not a guarantee of future results. Investors should consider the stated numbers as estimates within a speculative framework.
Tap a question to reveal the answer.
Avg $3.00, max $5.77, min $1.62, ROI 41.7, sentiment BULLISH.
Forecasts show bullish sentiment from 2028 onward with rising averages and ROIs; 2030 avg $3.00 (ROI 41.7%), 2040 avg $3.91 (ROI 84.4%), and 2050 avg $6.78 (ROI 220%). These are estimates, not guarantees.
Yes, the forecast includes a 2035 max of $9.48.
Low $0.6421, High $7.00.
Profusa, Inc. Community Discussion
0Share your Profusa, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.